|
000
| 02682nam 2200325za 4500 |
|---|
| 001 | 9.812533 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107141340 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170222s2016 onca o f100 0 eng d |
|---|
| 020 | |a978-0-660-04805-5 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aMR4-48/2016E-PDF |
|---|
| 111 | 2 |aHuman Immunology Consensus Workshop|d(2014 :|cToronto, Ont.) |
|---|
| 245 | 10|aHuman Immunology Consensus Workshop |h[electronic resource] : |bNovember 25th and 26th 2014, Sheraton Toronto Airport Hotel & Conference Centre, Toronto, On / |c[written by Isabelle Létourneau]. |
|---|
| 260 | |aOttawa : |bCanadian Institutes of Health Research, |cc2016. |
|---|
| 300 | |a39 p. : |bcol. ill. |
|---|
| 500 | |aIssued also in French under title: Atelier de consultation sur l'immunologie humaine : 25 et 26 novembre 2014, Sheraton Toronto Airport Hotel & Conference Centre, Toronto (Ont.). |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Written by: Isabelle Létourneau, PhD"--p. [2]. |
|---|
| 520 | |a"The Canadian Institute of Health Research (CIHR), Canada’s premier health research funding agency, is comprised of 13 virtual Institutes – one of which is the Institute of Infection and Immunity (III). In 2010, the Institute’s Advisory Board identified human immunology as a field in which strategic investment could have a significant impact in terms of knowledge and clinical outcomes. A consultation workshop was held to inform III and partner Institutes how best to strategically invest in human immunology research in Canada. Seventy-five participants represented research, research management and support or the pharmaceutical industry from across Canada, and included 2 International participants. The goals of the workshop were to stimulate discussion among the community; identify their needs; and hear from experts in human immunology on their work and perspectives regarding the state of research in terms of needs for moving forward. The workshop provided a forum to gather recommendations on how best to address current challenges, respond to the needs of the research community and have a positive impact on the health of Canadians”--Executive summary, p. 4. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 692 | 07|2gccst|aHealth |
|---|
| 692 | 07|2gccst|aMedical research |
|---|
| 700 | 1 |aLétourneau, Isabelle,|d1978- |
|---|
| 710 | 2 |aCIHR Institute of Infection and Immunity (Canada) |
|---|
| 775 | 08|tAtelier de consultation sur l'immunologie humaine |w(CaOODSP)9.812535 |
|---|
| 776 | 0#|tHuman Immunology Consensus Workshop |w(CaOODSP)9.812532 |
|---|
| 856 | 40|qPDF|s2.13 MB|uhttps://publications.gc.ca/collections/collection_2017/irsc-cihr/MR4-48-2016-eng.pdf |
|---|